|
|
OJHAS Vol. 8, Issue 3: (2009
Jul-Sep) |
|
|
A Prospective Analysis
of Adverse Drug Reactions in a South
Indian Hospital
|
|
Padmaja Uday Kumar, Professor and Head, Dept., of
Pharmacology, Fr. Muller's Medical College, Mangalore,
Prabha Adhikari, Professor, Dept., of Medicine, Kasturba
Medical College, Mangalore, Pratibha Periera, Professor,
Dept., of Medicine, Kasturba Medical College, Mangalore |
|
|
|
|
|
|
|
|
|
Address For Correspondence |
Dr Padmaja Uday Kumar, 1474, Raag, I Cross,
Falnir road, Mangalore 575002 INDIA
E-mail:
padmajaudaykumar@gmail.com |
|
|
|
|
Padmaja U, Adhikari P, Pereira P. A Prospective Analysis
of Adverse Drug Reactions in a South
Indian Hospital Online J Health Allied Scs.
2009;8(3):12 |
|
|
Submitted: Apr 15, 2009;
Suggested Revision: Sep 8, 2009; Revised: Sep 24, 2009; Accepted:
Sep 30, 2009; Published: Nov 15, 2009 |
|
|
|
|
|
|
|
|
Abstract: |
Adverse drug reactions are a great cause of concern to the medical profession, the patients and the pharmaceutical industry.
However ADR reporting and monitoring is yet to catch up in India. Hence we undertook a study to record and analyze adverse reactions among all patients admitted to
the medical wards of a tertiary care. Centre patients admitted to all medical wards over one year were assessed for ADRs throughout their admission. Suspected ADRs
were recorded and analyzed for i) the type of reaction ii) severity iii) Consequence on treatment that is if the drug was continued, or stopped, or needed to be treated
with other drugs, iv) Physiological system involved and the v) group of the drugs associated with ADRs. Among 1250 patients admitted during the study period, 250 adverse
events were observed. Majority (76.8%) were of mild type, 66% were severe requiring intensive care and 3 patients died. Antimicrobials were responsible for maximum (42.4%)
ADRs followed by drugs acting on CNS (20%). When we analyzed the systems affected, CNS side effects were more common in our study. While in many other studies Cardiovascular
and gastrointestinal side effects were the most common. Combination of drugs was responsible for a large percentage of ADRs. Inadvertent use of antipsychotics with sedatives
led to respiratory failure in 4 patients of which 1 died. Contaminated IV fluids are suspected to be the cause of death in another fatal ADR. In conclusion there is a need for
vigilant ADR monitoring to be done by all doctors to prevent morbidity and mortality from ADRs.
Key Words: Adverse drug reactions,
Monitoring, Antimicrobials, Combination of drugs, Hospital
|
|
There is general
agreement that drugs prescribed for disease are often themselves the
cause of a serious amount of disease (adverse reactions) ranging from
mere inconvenience to permanent disability and death. Since drugs are
intended to relieve suffering, patients find it particularly offensive
that they can also cause disease.
It is estimated
that adverse reactions cause 23 % of consultations in general
practice, upto 3% of admissions to intensive care units and 0.3% of
general hospital admissions are due to adverse drug reactions
(ADR).1 A recent study done in Sweden has implicated ADRs as the 7th
most common cause of death.2 Another study involving 19,000
admissions has shown that 6.5% of patient admissions were related to
an ADR.3 Data from older studies on ADRs occurring in in-patients
have suggested that 10-20% of patients experience ADRs in hospital.4-7
However these studies are decades old and with an increase in life expectancy
and development in medicine over the years, there is a need for more
data on the ADR in hospital in-patients.
Though ADRs
are of great concern to the general public, the medical profession,
the pharmaceutical industry and the regulatory authorities, the concept
of ADR reporting is still new in India. There are very few centres in
India to monitor ADRs and hardly any detailed ADR surveys done in India
are published.812 Hence a study was undertaken to record
and analyze all adverse reactions among hospitalized patients in the
medical wards of a tertiary care hospital in Mangalore, a South Indian
city.
A total
of 1250 patients
admitted to the medical wards of Kasturba Medical College Hospital,
Attavar, Mangalore, for a period of 1 year were observed for possible
ADRs, as per W.H.O. definition. W.H.O. has defined ADR as a noxious
or unintended response to a drug which occurs at doses normally used
in humans for prophylaxis, diagnosis or treatment of a disease or for
modifying the physiological function.13 However the term
adverse event is now frequently used to describe any untoward medical
occurrence that may be present during treatment with a pharmaceutical
product but which does not necessarily have a causal relationship with
the treatment.14 ADRs were identified by 2 physicians and
confirmed by a clinical pharmacologist. When there were doubts/disagreements,
such cases were not included. ADRs that occurred outside the hospital
and got admitted in our hospital were also included. Those who were
identified to have ADRs were examined and the details recorded in a
proforma, where details of the drugs taken, observed reactions, measures
taken for untoward reactions, investigations and response to measures
were recorded.
The results
were analyzed under the following headings:
- Type A or Type B
reaction1
- Severity
- Consequence of ADR
- Types of reactions
based on the system involved.
- Groups of drugs
commonly associated with ADR
- Type of reactions
and drugs commonly associated with it.
1. Type
A or augmented reactions are those that will occur in everyone if
enough of the drug is given because they are due to excess of normal,
predictable, dose related pharmacodynamic effects of a drug.
Type B or
bizarre reactions are those that are not part of normal pharmacology
of the drug, are not dose related and care due to unusual attributes
of the patient interacting with the drug. The class includes idiosyncrasies
and immunological processes and amount for most fatalities.
2. Severity
of ADR Mild adverse reactions were defined as those which did
not by itself require prolongation of hospitalization and could be managed
by simple measures, moderate were those ADRs which needed prolongation
of hospital stay of the patient for treatment of the same and severe
were life threatening ADRs.
3. Consequences
of ADRs were recorded under the following headings -
-
The patient
continued the drug
-
The dose had to
be reduced
-
The drug had to
be stopped/withdrawn
-
Another or more
drugs were needed to treat an adverse event.
4. Systems
involved Reactions were classified according to the system involved
i.e., percentage of involvement of different systems. Eg. Cardiovascular
system, central nervous system
5. Group
of the offending drug Drugs were classified according to groups
and frequency of ADRs noted in each group.
6. Details
of types of reactions Type of reaction noted and the drugs commonly
associated with the same were also recorded.
A total of 250 adverse
events were observed and recorded during the study period.
Type of
adverse event Table 1 shows the Types of reactions
Table 1:
Analysis Of Adverse Reactions |
Category
|
No |
Percentage |
Type
A (Augmented
reactions) |
80 |
32% |
Type B (Bizarre reactions) |
170 |
68% |
Total
|
250 |
100% |
Severity
(Table 2): We found a large fraction of ADRs (76.8%)
to be of mild type while 17.2% of the reactions were of moderate type
requiring prolongation of hospital stay of the patient for the treatment
of the event. Six percent of the reactions were severe requiring intensive care
and 3 patients (1.2%) died as a consequence of these events. Details
of moderate and severe reactions are mentioned in Table 3 and 4 respectively.
Table 2:
Analysis Of Adverse Reactions Based On The Severity |
ADE
Severity |
No |
Percentage |
Mild |
192 |
76.8% |
Moderate |
43 |
17.2% |
Severe |
Those requiring
intensive care |
12 |
4.8% |
Death due to ADR |
3 |
1.2% |
Total |
250 |
100% |
Table 3:
Moderate Reactions That Needed Prolonged Hospitalization |
Types
of reaction |
Offending drug |
Number |
I
Neurological |
a. Extrapyramidal reactions |
Haloperidol |
2 |
Chloroquine + metoclopramide* |
4 |
b. Convulsions |
Prochlorperazine |
1 |
Chloroquine |
3 |
c. Psychosis |
Lithium |
1 |
Theophylline*+ ciprofloxacin |
1 |
Lignocaine IV |
1 |
Chloroquine |
4 |
Corticosteroids |
1 |
Levodopa* + trihexiphenidyl |
2 |
Ranitidine |
1 |
Ciprofloxacin |
2 |
Total |
23 |
II
Cardio vascular |
a. AV Block |
Quinine |
1 |
b. Q-Tc prolongation |
Quinine |
1 |
c. Ventricular bigemini |
Digoxin |
1 |
d. Multiple ectopics |
Theophylline*+ salbutamol |
3 |
e. Unstable angina |
Pentoxyphylline |
1 |
Total |
7 |
III
Gastro intestinal |
a. GI Haemorrhage |
Aspirin * + ibuprofen* |
1 |
Aspirin |
2 |
b. Toxic hepatitis |
INH * + rifampicin*+ pyrazinamide* |
3 |
IV
Dermatological |
Exfoliative dermatitis |
Phenytoin |
2 |
V
Respiratory |
Pulmonary
tuberculosis |
Long term corticosteroids |
1 |
VI
Endocrine |
Hypoglycemia |
Sulphonylurea |
2 |
Quinine |
1 |
Severe Hyperglycemia |
Long term corticosteroids |
1 |
Gynacomastia |
Spironolactone |
2 |
*
probable offending drug |
Table 4:
Analysis Of Severe Reactions (Life Threatening) |
Types
of reaction |
Offending drugs |
Number |
Haematological |
Aplasia |
Carbamazepine |
1 |
Busulphan |
1 |
Massive haemorrhage |
Warfarin * + ibuprofen |
1 |
Prednisolone * + diclofenac* |
1 |
Respiratory failure |
Haloperidol + lorazepam* |
1 |
Diazepam |
2 |
Haloperidol + diazepam* |
1 |
Acute Renal Failure |
Gentamicin |
1 |
Naproxen |
1 |
Acute Pancreatitis |
Etoposide |
1 |
Cardiac arrhythmias |
Theophylline* + norfloxacin |
1 |
Theophylline* + salbutamol |
1 |
Angioneurotic oedema |
Diclofenac |
1 |
Anaphylaxis |
Contaminated IV fluid |
1 |
Stevens Johnson syndrome |
Sulfonamide, Haloperidol
+ lorazepam |
1 |
|
Total |
16 |
*
probable offending drug |
Details
of ADR death:
Case 1:
Elderly female of 70 years was prescribed corticosteroids for radiation pneumonitis which she developed following treatment of carcinoma breast.
She was initially given a high dose of 60 mg/day prednisolone which
was tapered to a maintenance dose of 10 mg/day. She developed acute
abdominal pain and relatives gave diclofenac 1 tab thrice a day on day
1 and 2 tablets thrice a day on day 2. She died of massive upper gastrointestinal
haemorrhage.
Case 2: A young girl (18 yrs) was admitted for ibuprofen (for chondritis
costo) induced gastritis and persistent vomiting. Intravenous fluids
were started, and the patient developed stridor, hypotension and suddenly
died. Autopsy did not reveal any other cause of death. Presumed cause
of death was intravenous fluid induced anaphylaxis, as same batch of
fluids was found to be contaminated with fungi.
Case 3: An elderly male of 70 with COPD developed restlessness and hallucinations
following intravenous ciprofloxacin for lower respiratory infection.
He was sedated with diazepam (10 mg). The patient developed severe type
II respiratory failure.
Consequence
of ADR: Table 5 shows the effect of ADR on the treatment of the
primary disease.
Table 5:
Consequence of ADR on The Treatment of Primary Disease |
Consequence
|
No.
|
Percentage
|
Patient
continued the drug
|
62
|
24.8% |
Dose
had to be reduced
|
56 |
22.4% |
Drug had to be stopped |
122 |
48.8% |
ADR developed after stopping
the drug |
10 |
4.0 |
Total |
250 |
100% |
ADR
needed treatment with other drugs |
75 |
30% |
Classes
of drugs: When we analyzed the classes of drugs responsible for
adverse events in the order of their frequency, we found that antimicrobial
agents including antimalarials were the drugs which caused maximum number
of adverse effects (Table 6). Anticancer drug related effects were only
4% because we have a separate unit for treatment of cancers. Among the
hormones, most frequent offending agents were corticosteroids.
Table 6:
Adverse Events According to Class of Drug Involved |
Drug
class |
No of events |
Weighted Percentage |
Antimicrobial
agents |
106 |
42.4% |
Antimalarials |
70 |
|
Antibiotics |
23 |
|
Antitubercular drugs |
13 |
|
Drugs
acting on central nervous system |
50 |
20% |
Antipsychotics |
18 |
|
Analgesics |
14 |
|
Antiseizure |
8 |
|
Sedatives |
7 |
|
Antiparkinsonian |
3 |
|
Hormones |
31 |
12.4% |
Corticosteroids |
24 |
|
Other
hormones |
7 |
|
Cardiovascular
drugs |
20 |
8% |
Antihypertensives |
13 |
|
Antianginal |
5 |
|
Antiarrhythmics |
1 |
|
Digoxin |
1 |
|
Others |
Respiratory system |
18 |
7.2% |
Diuretics |
7 |
2.8% |
Water for injection |
6 |
2.4% |
Anticancer drugs |
4 |
1.6% |
Anticoagulants |
4 |
1.6% |
Miscellaneous |
4 |
1.6% |
Total |
250 |
100% |
Systems
involved: Table 7 shows the systems affected and the number of
patients affected. Table 8 shows the type of reaction under each system
and the offending drugs that were associated with the same.
Table 7:
The Extent of Involvement of Various Systems by the Adverse Events |
Systems
Involved |
Number |
Weighted Percentage |
Central
nervous system |
60 |
23.8% |
Hypersensitivity or Allergic reactions
|
40 |
15.4% |
Digestive system |
38 |
14.62% |
Cardiovascular system |
25 |
9.6% |
Musculoskeletal system |
18 |
6.92% |
Blood |
10 |
3.85% |
Dermatological manifestations |
10 |
3.85% |
Respiratory system |
5 |
1.9% |
Hepatic function |
4 |
1.54% |
Renal function |
4 |
1.54% |
Miscellaneous |
46 |
17.7% |
Total |
260 |
100% |
Footnote:
Some drugs affected multiple systems and therefore we have >250 reactions
|
Table
8: System wise Classification Of 250 ADRs With The Possible Offending Drugs |
I
Central Nervous System |
a) Headache |
Nitrates, chloroquine |
b)
Insomnia |
Chloroquine, trihexyphenidyl, prednisolone |
c)
Psychosis |
Chloroquine, levodopa, trihexyphenidyl, prednisolone,
ranitidine, ciprofloxacin & methyldopa |
d)
Depression |
Chloroquine, reserpine & methyldopa |
e)
Convulsions |
Chloroquine, levodopa, lignocaine, theophylline |
f)
Respiratory depression |
Diazepam, chloropromazine, haloperidol, lorazepam |
g) Ptosis |
Diazepam |
h) Dysarthria |
Diazepam, chloropromazine |
i) Extrapyramidal
Reactions |
Chloroquine, metoclopromide, haloperidol, chloropromazine |
j) Ataxia, nystagmus |
Carbanazepine |
k)
tingling, numbness |
Enalapril |
II
Cardiovascular System |
a. Angina |
Pentoxyphylline |
b.
Arrhythmias |
Digoxin, theophylline, salbutamol, quinine, chloroquine |
c. AV block |
Quinine |
d. Oedema |
Nifedipine, prednisolone |
e.
Hypotension |
Enalapril |
f.
Hypertension |
Corticosteroids |
III
Gastro intestinal system |
a. Gastro intestinal
haemorrhage |
Aspirin, dicofenac, ibuprofen,
warfarin, prednisolone |
b. Nausea,
Vomiting, dyspepsia |
Cotrimoxazole, erythromycin,
pyrazinamide, Chloroquine, griseofulvin, rifampicin, ramipril,
theophylline, diclofenac, prednisolone |
c)
Hepatitis |
INH, rifampicin, pyrazinamide, ticlopidine |
d) Acute Pancreatitis |
Etoposide |
e) Diarrhoea |
Amoxycilline, warfarin |
f) Loss
of appetite |
Tinidazole |
g) Dry
mouth |
Imipramine |
h)
Gingival hyperplasia |
Phenytoin |
i) Oral
ulcers |
Diclofenac |
IV
Renal |
|
a. Dysuria |
Trihexyphenidyl |
b.
Nephropathy |
Diclofenac, gentamicin |
c. Incontinence &
Polyuria |
Lithium |
V
Dermatological |
a) Pruritus |
Erythromycin, spironolactone, Ampicillin, Ibuprofen, Ciprofloxacin, vitamin injection, phenolphthalein, salbutamol,
cotrimoxazole, metronidazole, INH, rifampicin, nifedipine,
insulin, cloxacillin, Chloroquine, doxycycline, theophylline
|
b)
Rashes |
Erythromycin,
Ibuprofen, Ampicillin, paracetamol, Ciprofloxacin, theophylline, ozothine, Chloroquine,
primaquine, cotrimoxazole
|
c)
Pigmentation |
Busulphan |
d) Acne |
Prednisolone |
e) Erythema Multiformae |
Sulpha, Haloperidol, Chlorpromazine, Lithium, carbanazepine |
f) Exfoliative
dermatitis |
Phenytoin, Phenobarbitone, Doxycycline,
Sulpha |
VI
Haematological |
Pancytopenia |
Busulphan, carbanazepine |
Petechiae &
purpura |
Rifampicin, Prednisolone |
VII
Musculoskeletal System |
a. Cramps |
Triamterene, Thiazides, Chloroquine |
b. Myopathy |
Corticosteroids, chloroquine |
c) Arthralgia |
Pyrazinamide |
d)
Muscle tremors |
Salbutamol, theophylline |
VII
Multisystem involvement |
a.
Anaphylaxis |
Penicillin, Ozothine, Intravenous fluid |
b. Angio oedema |
Ciprofloxacin, metronidazole |
c. Febrile
reactions |
Water for
injection |
Previously
unreported ADRs
1.
Etoposide induced pancreatitis: An adult male (35 yrs) suffering
from seminoma testis was treated with etoposide as part of a multidrug
regimen. With the first dose of etoposide, patient developed acute pancreatitis.
Etoposide was stopped and the patient recovered. But, etoposide was
repeated as part of the regimen following which pancreatitis developed
again. This established the cause - effect relationship beyond reasonable
doubt as definite (rechallenge). The drug was never repeated in
the patient. The case has been reported15.
2. IV fluids
induced anaphylaxis: Though reactions to intravenous fluids have
been mentioned in the literature, to the best of our knowledge, no cases
of intravenous fluid induced anaphylaxis have been reported. The current
practices of using delicate containers make them more susceptible to
damage and lead to contamination. A case has been described above.
Adverse drug
reactions are a common occurrence, but are often not recognized. Even
if they are recognized they are under-reported as many physicians are
unaware that clinically important ADRs should be reported to ADRs monitoring
centres. In our series of 1250 hospitalized patients we found a high
incidence of ADR 16.66% of which 1.2% were fatal ADRs. In a meta analysis
of all prospective studies of ADRs in US hospitals16 by Lazarou
et al an overall incidence of 15.1% ADR was detected of which 6.7% were
serious ADRs with a fatal ADR incidence of 0.32%. Our results are comparable.
The majority
of our reactions were Type B reactions (68%) which indicate that most
of our reactions were inevitable and unavoidable in contrast to the
meta analysis by Lazarou et al16, where 76.2% were Type A
reactions. The cause for this discrepancy may be due to inclusion of
large number of reactions to antimalarials and other antimicrobials
(42.4%) in our set up.
Majority of
our patients had mild reactions while 23.2% of cases had moderate to
severe reactions of which 6% had serious reactions and of them 1.2%
were fatal. Various other studies have quoted an incidence of serious
ADRs to be 0 - 20% with a fatality rate of 0 0.8%. Table 9 shows
various studies of ADRs on the incidence and severity and their comparison
with the present study. A pilot study of 125 in-patients done in UK
showed that 19% of patients suffered from ADRs with patients spending
6.5 days longer in hospital than those without ADRs.17 However
many of the studies have included only patients admitted to the hospitals
for ADR or patients who developed ADR after admission to the hospital.
Our study has included both the groups.
It is interesting
to note that 30% of ADRs had to be treated with another drug adding
to the cost of therapy and prolonging hospitalization. Cassen et al18
have proved in a study that attributable lengths of stay and costs of
hospitalization for ADRs are substantial and they have also concluded
that it is responsible for 2 fold increased risk of death. Bates et
al19 in an article have estimated that the annual costs attributable
to all ADE for a 700 bed teaching hospital is 5.6 million dollars.
Regarding class
of drugs associated with ADRs antimicrobials rank high in the list as
they are the most commonly prescribed drugs in our set up. Similar observation
was noted in an Indian study.2 In a study by Caranasos20
et al, antimicrobials were the second most common cause of ADRs while
non narcotic analgesics topped the list. Kanjanarat et al21
noted cardiovascular drugs to be causative in 17.9% of ADRs while Lakshmanan
et al22 in a study of hospital admissions due to iatrogenic
illness, found antihypertensives to be responsible for most of the iatrogenic
admissions. However the latter study included moderate to severe reactions
only and our study has included mild side effects also. Steel et al23
also have found low percentage of antibiotic related iatrogenic illness.
Bates et al24 in a study of 247 patients found 30% of ADRs
to be due to analgesics, 24% due to antibiotics, 8% due to sedatives
and 7% due to antineoplastic drugs. Davies et al in UK25,
have found the most frequent ADR causative drugs relative to usage to
be opioid analgesics, anticoagulants, fibriolytics, systemic glucocorticoids,
diuretics and antibiotics. However, these differences seen in different
places could also be due to the variation in drug usage and disease
prevalence in different places.
Table 9:
Comparative Studies on ADRs in Patients While in Hospital |
Authors |
Study
size |
Incidence of
ADRs % |
All severities |
Serious |
Fatal |
Davies et al 2009 |
3322 |
15.8 |
15.2 |
0.4 |
Bates et al 1995 |
379 |
5.3 |
0.8 |
0 |
Bates et al 1995 |
4031 |
4.4 |
1.5 |
0 0.8 |
Bates et al 1993 |
420 |
3.6 |
1.9 |
0 |
Steel at al 1981 |
815 |
14.8 |
2.8 |
- |
Mitchell et al 1979 |
1669 |
16.8 |
- |
- |
Our series |
1250 |
20 |
0.96 |
0.24 |
When we analyzed
the systems affected most of them were CNS side effects (23.1%) which
is much lower than 77.2% reported in a systematic review of ADRs by
Thomsen et al.26 This is in contrast to previous studies
where gastrointestinal side effects were more frequent as in the study
by Natalie et al.27 However they too noted that neuromuscular
problem was quite frequent with an incidence of 22.6% whereas
Caranasos20 et al found 22.2% cardiovascular ADRs and 18.5%
gastrointestinal ADRs with only 11.1% neurologic ADRs in a study
of 189 ADRs. This discrepancy may be due to inclusion of large number
of antimalarials which produced CNS side effects.
Among moderate
to severe reactions, combinations of drugs (drug interactions) were
responsible for a large percentage of ADRs. 41.1% of ADRs in severe
reactions, 29% of cases in moderate reactions and 66.6% of fatal reactions
were all due to combination of drugs. One important observation was
that of inadvertent use of antipsychotics and sedatives for patients
with respiratory failure in 4 cases of which one died. As patients with
respiratory failure may present with psychotic symptoms one should be
careful about sedating a patient with preexisting respiratory failure.
Drug-drug interactions were linked to 59% of ADRs in a study by Davies
et al.25 Polypharmacy was implicated by them to be the cause
in a large percentage of cases where incidence of ADR was higher in
patients receiving higher number of drugs compared to those receiving
fewer drugs.
It is important
to note that commonly used drugs such as chloroquin can produce serious
neuropsychiatric problems such as extrapyramidal reactions, convulsions
and psychosis as seen in 11 of our patients. If this fact is not considered,
these patients may end up with unnecessary investigations such as lumbar
puncture, EEG and a CT scan.
Our study has
included reactions to water for injections and IV fluids. Although it
cannot be considered as a true ADR, it can be considered as an adverse
drug event. Intravenous fluids have been associated with reactions such
as rigors and rarely anaphylaxis. In one of our fatal cases this is
suspected, because an IV fluid bottle of the same company was found
to have overt fungal growth in a few bottles.
We also found
a case of etoposide induced pancreatitis15 which was unknown
previously.
In conclusion,
ADR monitoring has to be carried out by all the doctors, as the pattern
of ADR may vary from place to place and time to time. By early recognition
of these reactions, necessary action can be taken to prevent mortality
and morbidity from such reactions.
The authors
are grateful to the Department of Pharmacology, KMC Mangalore for their
help in framing the proforma.
- Lawrence
DR, Bennett PN, Brown MJ. Unwanted effects and adverse drug
reactions. In Lawrence DR, Bennett PN,
Brown MJ (Eds.). Clinical Pharmacology 8th Edn Longman
Singapore Publishers, Singapore. 1997. p. 121137.
-
Wester K,
Jonnson AK, Sigset O, Druid H, Hagg S. Incidence of fatal
adverse drug reactions: a population based study. Br J Clin Pharmacol
2008;65:573-579
-
Pirmohamed
M, James S, Meakin S, Green C, Scott AK et al. Adverse
drug reactions as a cause of admission to hospital: prospective analysis
of 18,820 patients. BMJ 2004;329:15-19
-
Seidi LG,
Thornton GF, Cluff LE. Epidemiological studies of adverse
drug reactions. Am J Public Health 1965;65:1170-1175.
-
Smith JW,
Seidi LG, Cluff LE. Studies on the epidemiology of adverse drug
reactions. V-clinical factors influencing susceptibility. Ann Int Medicine
1966;65:629-639
-
Hurwitz
N, Wade OL. Intensive hospital monitoring of adverse reactions
to
drugs. BMJ 1969;1:531- 536.
-
Ogilvie
RI, Ruedy J. Adverse drug reactions during hospitalization. Canadian
Medical Association Journal 1967;97:1450-1457
-
Bhattacharya
SK, Prasad RC, Sinha PR. Some unusual and severe forms of adverse
drug reactions. A call for setting adverse drug reaction monitoring centres. J Assoc
Phys India. 1998;46:6757
-
Kshirsagar
NA, Karande SC, Potkar CN. A prospective survey of drug induced hepatotoxicity in a large hospital.
Indian J Gastroenterol. 1992;11:1315.
-
Karande
SC, Kshirsagar NA. Adverse drug reactions in children in developing
countries. Natl. Med J India. 1996;9(5):218221.
-
Uppal R,
Thaj R, Malhotra S. Adverse drug reactions to fluoroquinolones at a
tertiary care hospital in northern India. J Assoc Phys Ind. 1998;46:946947
-
Adhikari
P, Padmaja U, Pereira P, Chowta N. Lesser known side effects of chloroquine A South Indian Experience.
Indian J Clin Pharmac. 1997;18:16-19
-
World Health Organisation. International drug monitoring The role of the
hospital, Geneva. World Health Organisation 1966. Technical Report Series
No.
425.
-
Bates DB, Leape LL, Petrychi S, Incidence and preventability of adverse drug
events in hospitalized adults. J Gen Intern Med. 1993;8:289-294
-
Adhikari
P, Pereira P, Chowta N. Acute pancreatitis following etoposide therapy
for testicular tumor. Ind J Med and Ped Oncol. 1995;16:6677
-
Lazarou J,
Pomeranz B, Corey PN. Incidence of adverse drug reactions in hospitalized
patients. JAMA. 1998;279:12001205
-
Davies
EC, Green CF, Mottram DR, Pirmohamed M. Adverse drug reactions
in hospital in-patients: a pilot study. J Clin Phar Ther 2006;31:335-341.
-
Cassen
DC, Stanley L, Evans S, Lloyd JF, Burke JP. Adverse drug events in
hospitalized patients. Excess length of stay, extra costs and attributable
mortality. JAMA. 1997;277:301-305.
-
Bates D,
Spell Nathow, Cullen DJ, Buridick E, Laird W Petersen L et al. The costs
of adverse drug events in hospitalized patients. JAMA. 1997;277:307311
-
Caranasos
GJ, Stewart RB, Cluff LE. Drug induced illness leading to
hospitalization. JAMA. 1974;228:713717
-
Kanjanarat
P, Winetrstein AG, Johns TE, Hatton RC et al. Nature of preventable
adverse drug events in hospitals: a literature review. Am J Health Syst Pharm 2003 Sep 1;60(17):1750-9.
-
Lakshmanan
MC, Hershey Co, Brealan D. Hospital admission caused by
iatrogenic disease. Arch Intern Med. 1986;146:19311934
-
Steel K, Gertman PM, Crescenzi C, Anderson J. Iatrogenic illness on a general
medical services at a university hospital. N Eng J Med. 1981;304:638642
-
Bates DW,
Cullen DJ, Lavid N. Incidence of adverse drug events and potential
adverse drug events, implications for prevention. JAMA. 1995;274:2934.
-
Davies
EC, Green CF, Taylor S., Williamson PR, Motram DR et al. Adverse Drug
Reactions in hospital in-patients: A prospective analysis of 3695 patient-episodes. Plos ONE 2009;4(2): e4439.doi:10.1371/journal.pone.0004439
-
Thomsen
LA, Winterstein AG, Sondergaard B, Haugbolle LS et al. Systematic
review of the incidence and characteristics of preventable adverse drug
events in
ambulatory care. Ann Pharmacother. 2007 Sep;41(9):1411-26.
-
Natalie
H, Wade OL. Intensive hospital monitoring of adverse reactions to drugs.
Brit Med J. 1969;1:531536
|